Rikkunshito, an Herbal Medicine, Suppresses Cisplatin-Induced Anorexia in Rats Via 5-HT2 Receptor Antagonism

      Background & Aims: Chemotherapy with an anticancer agent generally causes gastrointestinal tract disorders such as vomiting and anorexia, but the mechanism remains unclear. Rikkunshito, a kampo preparation, is known to alleviate such adverse reactions. In this study, we attempted to clarify the mechanism. Methods: We investigated the decreases of plasma acylated-ghrelin level and food intake caused by cisplatin, serotonin (5-HT), 5-HT agonists, and vagotomy as well as the decrease-suppressing effects of rikkunshito and 5-HT antagonists. In addition, binding affinities of rikkunshito components were determined in receptor-binding assays using 5-HT2B and 5-HT2C receptors. Results: Cisplatin, 5-HT, BW723C86 (5-HT2B–receptor agonist), and m-chlorophenylpiperazine HCl (5-HT2C agonist) markedly decreased plasma acylated-ghrelin levels, although 5-HT3 and 5-HT4 agonists had no effect. In contrast, 5-HT2B and 5-HT2C antagonists suppressed the cisplatin-induced decrease of plasma acylated-ghrelin level and food intake. Administration of rat ghrelin improved the cisplatin-induced decrease in food intake. Vagotomy decreased the plasma acylated-ghrelin level, which was decreased further by cisplatin. Rikkunshito suppressed such cisplatin-induced decreases of plasma acylated-ghrelin level and food intake. The suppressive effect of rikkunshito was blocked by a ghrelin antagonist. Components of rikkunshito, 3,3′,4′,5,6,7,8-heptamethoxyflavone, hesperidin, and iso-liquiritigenin showed a 5-HT2B-antagonistic effect in vitro, and oral administration of rikkunshito suppressed the cisplatin-induced decrease in the plasma acylated-ghrelin level. Conclusions: The cisplatin-induced decreases of the plasma acylated-ghrelin level and food intake are mediated by 5-HT2B/2C receptors and suppressed by flavonoids in rikkunshito.

      Abbreviations used in this paper:

      CPB (1-(3-chlorophenyl) biguanide HCl), GHRP-6 ([D-Lys3]–ghrelin receptor antagonist), HMF (3,3′,4′,5,6,7,8-heptamethoxyflavone), 5-HT (serotonin), Ki (inhibition constant 5-HT2B/2C–receptor binding-inhibitory activities), mCPP (m-chlorophenyl piperazine HCl), CD (hydroxypropyl-β-cyclodextrin)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cubeddu L.X.
        • Hoffmann I.S.
        Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatin-based chemotherapy: effects of antiemetics.
        J Clin Pharmacol. 1993; 33: 691-697
        • De Vry J.
        • Schreiber R.
        Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action.
        Neurosci Biobehav Rev. 2000; 24: 341-353
        • Kursar J.D.
        • Nelson D.L.
        • Wainscott D.B.
        • et al.
        Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine 2F) from rat stomach fundus.
        Mol Pharmacol. 1992; 42: 549-557
        • Wright D.E.
        • Seroogy K.B.
        • Lundgren K.H.
        • et al.
        Comparative localization of serotonin 1A, 1C and 2 receptor subtype mRNAs in rat brain.
        J Comp Neurol. 1995; 351: 357-373
        • Nonogaki K.
        • Strack A.M.
        • Dallman M.F.
        • et al.
        Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene.
        Nat Med. 1998; 4: 1152-1156
        • Hayashi A.
        • Suzuki M.
        • Sasamata M.
        • et al.
        Agonist diversity in 5-HT2C receptor-mediated weight control in rats.
        Psychopharmacology. 2005; 178: 241-249
        • Kojima M.
        • Hosoda H.
        • Date Y.
        • et al.
        Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
        Nature. 1999; 402: 656-660
        • Asakawa A.
        • Inui A.
        • Kaga T.
        • et al.
        Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.
        Gut. 2003; 52: 947-952
        • Shinomiya T.
        • Fukunaga M.
        • Akamizu T.
        • et al.
        Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients.
        Scand J Gastroenterol. 2005; 40: 648-653
        • Isomoto H.
        • Ueno H.
        • Nishi Y.
        • et al.
        Circulating ghrelin levels in patients with various upper gastrointestinal disease.
        Dig Dis Sci. 2005; 50: 833-838
        • Yagi M.
        • Homma S.
        • Kubota M.
        • et al.
        The herbal medicine Rikkunshi-to stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgery.
        Pediatr Surg Int. 2004; 19: 760-765
        • Tatsuta M.
        • Iishi H.
        Effect of treatment with liu-jun-zi-tang(TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients.
        Aliment Pharmacol Ther. 1993; 7: 459-462
        • Tomono H.
        • Ito Y.
        • Watanabe T.
        Successful antiemetic treatment of Tsumura rikkunshi-to extract granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient.
        Jpn J Cancer Chemother. 2006; 33: 1129-1131
        • Miyoshi A.
        • Yachi A.
        • Masamune O.
        • et al.
        Clinical evaluation of the efficacy of TJ-43 Tsumura Rikkunshi-to on chronic gastritis with abdominal symptom-multicenter groups study in comparison with cisapride.
        Prog Med. 1991; 11: 1605-1631
        • Kido T.
        • Nakai Y.
        • Kase Y.
        • et al.
        Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine.
        J Pharmacol Sci. 2005; 98: 161-167
        • Masuda Y.
        • Tanaka T.
        • Inomata N.
        • et al.
        Ghrelin stimulates gastric acid secretion and motility in rats.
        Biochem Biophys Res Commun. 2000; 276: 905-908
        • Wolf W.A.
        • Schuts J.S.
        The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia; evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
        J Neurochem. 1997; 69: 1449-1458
        • Butcher M.E.
        Global experience with ondansetron and future potential.
        Oncology. 1993; 50: 191-197
        • Ozaki A.
        • Sukamoto T.
        Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
        Gen Pharmacol. 1999; 33: 283-288